HBHarry J. Buncke

Harry J. Buncke

*This is an algorithmically generated author record based on publicly available information.

Harry J. Buncke has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Induction of tolerance to composite tissue allograft in a rat model

    by Fabio Quatra, David W. Lowenberg, Harry J. Buncke, Oreste M. Romeo, Darrell Brooks, Rudolf F. Buntic, Lee A. Baxter-Lowe

    The goal of this study was to establish a rat model that can be used to determine the variables in influencing induction of tolerance to composite tissue allografts. An anti T‐cell depleting agent (R73) and 15‐deoxyspergualin were given in different doses and schedule to four groups of Lewis rats receiving a limb transplant from Brown‐Norway donors. Graft survival prolongation was maximal combining a single dose of R73 and a 20‐day administration of 15‐deoxyspergualin. Long‐term survivors accepted a skin graft from Brown‐Norway donors at 80 days, but rejected grafts from an unrelated donor. Skin grafting did not influence survival of the transplanted limb. Mixed allogeneic chimerism was not detectable in peripheral blood by flow cytometry, but immunohistochemistry identified donor‐derived cells in the thymus of tolerant recipients at 100 days. These results suggest a state of donor‐specific, dynamic tolerance, with potential for future application in human composite tissue allotransplantation. © 2006 Wiley‐Liss, Inc. Microsurgery, 2006


    • 1 January 2003
      • Vol. 11, 292-302

    Composite tissue allografting (CTA).

    by Harry J Buncke, David W Lowenberg, Fabio Quatra, Gregory M Buncke, Rudolf F Buntic, Darrell Brooks

    Composite tissue allografting (CTA) is a relatively new term that appears with increased frequency in the medical and surgical literature. The recent successful allografts, or homotransplantations, of hands has sparked a resurgence of research, both experimental and clinical. Plastic surgeons have long been interested--particularly in the field of skin grafts for extensive burns and wounds--but have been replaced by the organ transplant teams and immunogeneticists. The skin, one of the most strongly antigenic organs, has required such high levels of immunosuppressive drugs to date, that elective transplants of skin and other composite tissues have received little attention.

  • The Effect of an Implantable Doppler Probe on the Salvage of Microvascular Tissue Transplants

    by Gabriel M. Kind, Rudolf F. Buntic, Gregory M. Buncke, Timothy M. Cooper, Peter P. Siko, Harry J. Buncke, William M. Swartz

  • The Effect of an Implantable Doppler Probe on the Salvage of Microvascular Tissue Transplants

    by Gabriel M. M.D. Kind, Rudolf F. M.D. Buntic, Gregory M. M.D. Buncke, Timothy M. M.D. Cooper, Peter P. M.D. Siko, Harry J. Jr. M.D. Buncke

    One hundred forty-seven flaps in 135 consecutive patients undergoing microvascular transplantation were monitored using a miniature Doppler ultrasonic probe. Using a modification of a technique described previously by Swartz, the probes were secured to the outflow vein of the flap with Vicryl mesh. Twenty instances of thrombosis or spasm were detected in 16 patients, and all flaps were salvaged (100 percent). There were four false positive and no false negative results. This probe allows for safe, continuous monitoring of flap blood flow, which permits the rapid detection and hence rapid treatment of postoperative complications. Our experience suggests that a significant improvement in the salvage rate of microvascular transplants may be attainable with the use of this device. (Plast. Reconstr. Surg. 101: 1268, 1998.)